Atlas Trials

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Clinical trial NCT05495100 · UNKNOWN

Trial details

NCT number
NCT05495100
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma
Start date
2022-08-11
Primary completion
2023-08-11
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.